{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:39:35Z","timestamp":1788273575862,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-07148-y","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T14:37:54Z","timestamp":1764167874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1\/TLR4\/NF-kB\/ACE2 axis in rats"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1178-9743","authenticated-orcid":false,"given":"Mert","family":"Zeytinoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aras","family":"Erdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sefa","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Sami","family":"Demirsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Tu\u011frul","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necla","family":"De\u011fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar Sava\u015f","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Aygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oytun","family":"Erba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"7148_CR1","first-page":"2714","volume-title":"Oral complications: principles and practice of oncology","author":"AM -Berger","year":"1997","unstructured":"-Berger AM, Kilroy TJ. In: DeVita VJ Jr, Hellmen S, Rosenberg SA, editors. Oral complications: principles and practice of oncology. 5th ed. Philadelphia, PA: Lippincott Raven; 1997. p. 2714.","edition":"5"},{"key":"7148_CR2","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1080\/14656566.2016.1217993","volume":"17","author":"A Villa","year":"2016","unstructured":"Villa A, Sonis ST. Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharmacother. 2016;17:1801\u20137.","journal-title":"Expert Opin Pharmacother"},{"key":"7148_CR3","doi-asserted-by":"publisher","unstructured":"Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol. 2017;7:89. https:\/\/doi.org\/10.3389\/fonc.2017.00089.","DOI":"10.3389\/fonc.2017.00089"},{"issue":"5","key":"7148_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1593\/neo.04169","volume":"6","author":"MUR Naidu","year":"2004","unstructured":"Naidu MUR, Ramana GV, Rani PU, Suman A, Roy P. Chemotherapy-induced and\/or radiation therapy-induced oral mucositis-complicating the treatment of cancer. Neoplasia. 2004;6(5):423\u201331.","journal-title":"Neoplasia"},{"key":"7148_CR5","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.ejon.2005.08.004","volume":"9","author":"R Stone","year":"2005","unstructured":"Stone R, Fliedner MC, Smiet AC. Management of oral mucositis in patients with cancer. Eur J Oncol Nurs. 2005;9:S24-32.","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"7148_CR6","first-page":"1","volume":"33","author":"Y Jin","year":"2025","unstructured":"Jin Y, Wang J, Wang Y. Unraveling the complexity of radiotherapy-and chemotherapy-induced oral mucositis: insights into pathogenesis and intervention strategies. Support Care Cancer. 2025;33(3):1\u201313.","journal-title":"Support Care Cancer"},{"issue":"1","key":"7148_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8.","journal-title":"Int J Oral Sci"},{"key":"7148_CR8","doi-asserted-by":"crossref","unstructured":"Zhong M, Lin B, Pathak JL, Gao H, Young AJ, Wang X, Wang L. ACE2 and furin expressions in oral epithelial cells possibly facilitate COVID-19 infection via respiratory and fecal\u2013oral routes. Front Med. 2020;7:580796.","DOI":"10.3389\/fmed.2020.580796"},{"issue":"48","key":"7148_CR9","doi-asserted-by":"publisher","first-page":"40364","DOI":"10.1074\/jbc.M509329200","volume":"280","author":"J -Chen","year":"2005","unstructured":"-Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem. 2005;280(48):40364\u201374.","journal-title":"J Biol Chem"},{"key":"7148_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"HB Zhang","year":"2020","unstructured":"Zhang HB, Penninger JM, Li YM, Zhong NS, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586\u201390. https:\/\/doi.org\/10.1007\/s00134-020-05985-9.","journal-title":"Intensive Care Med"},{"key":"7148_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ejca.2007.02.001","volume":"43","author":"L Sung","year":"2007","unstructured":"Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S. Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer. 2007;43:1269\u201375. https:\/\/doi.org\/10.1016\/j.ejca.2007.02.001.","journal-title":"Eur J Cancer"},{"issue":"8","key":"7148_CR12","volume":"31","author":"E Jahanbani Mazraeh","year":"2023","unstructured":"Jahanbani Mazraeh E, Sadighi S, Manifar S, Bakhshandeh H, Rajabi M. Assessment of thyme honey oral gel for the prevention of adriamycin and cyclophosphamide chemotherapy-induced oral mucositis in patients with breast cancer. Support Care Cancer. 2023;31(8):497.","journal-title":"Support Care Cancer"},{"issue":"1","key":"7148_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-020-02876","volume":"95","author":"ZH -Maayah","year":"2021","unstructured":"-Maayah ZH, Takahara S, Dyck J. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin. Arch Toxicol. 2021;95(1):1\u20139. https:\/\/doi.org\/10.1007\/s00204-020-02876-.","journal-title":"Arch Toxicol"},{"issue":"2","key":"7148_CR14","doi-asserted-by":"publisher","first-page":"H460","DOI":"10.1152\/ajpheart.00056.2019","volume":"317","author":"DZ -Tavakoli","year":"2019","unstructured":"-Tavakoli DZ, Singla DK. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis. Am J Physiol Heart Circ Physiol. 2019;317(2):H460\u201371. https:\/\/doi.org\/10.1152\/ajpheart.00056.2019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7148_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s12020-021-02807-w","volume":"74","author":"F Coperchini","year":"2021","unstructured":"Coperchini F, Ricci G, Croce L, Denegri M, Ruggiero R, Villani L, et al. Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study. Endocrine. 2021;74:638\u201345.","journal-title":"Endocrine"},{"issue":"1","key":"7148_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03716-w","volume":"20","author":"X Zuo","year":"2022","unstructured":"Zuo X, Ren S, Zhang H, Tian J, Tian R, Han B, et al. Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1\u03b1 signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy. J Transl Med. 2022;20(1):509.","journal-title":"J Transl Med"},{"issue":"1","key":"7148_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70066","volume":"13","author":"N Yoshikawa","year":"2025","unstructured":"Yoshikawa N, Hirata N, Kurone Y, Shimoeda S. Edaravone is a therapeutic candidate for Doxorubicin-induced cardiomyopathy by activating the Nrf2 pathway. Pharmacol Res Perspect. 2025;13(1):e70066.","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"7148_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031633","volume":"25","author":"E Duranti","year":"2024","unstructured":"Duranti E, Cordani N, Villa C. Edaravone: a novel possible drug for cancer treatment? Int J Mol Sci. 2024;25(3):1633.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7148_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jphs.2015.02.001","volume":"127","author":"N Nakajima","year":"2015","unstructured":"Nakajima N, Watanabe S, Kiyoi T, Tanaka A, Suemaru K, Araki H. Evaluation of Edaravone against radiation-induced oral mucositis in mice. J Pharmacol Sci. 2015;127(3):339\u201343.","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"7148_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1179\/1351000215Y.0000000011","volume":"20","author":"MQ Hassan","year":"2015","unstructured":"Hassan MQ, Akhtar MS, Akhtar M, Ali J, Haque SE, Najmi AK. Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: biochemical and ultrastructural evidence. Redox Rep. 2015;20(6):275\u201381.","journal-title":"Redox Rep"},{"key":"7148_CR21","doi-asserted-by":"publisher","unstructured":"Tun\u00e7 E, Aygun H, Erba\u015f O. A Low Dose of Edaravone Decreases the Epileptiform Activity in the Absence Epilepsy Model by Reducing Oxidative Stress and Neuroinflammation. Bratisl. Med. J. 2025;126:1673\u20131681. https:\/\/doi.org\/10.1007\/s44411-025-00195-5.","DOI":"10.1007\/s44411-025-00195-5"},{"issue":"8","key":"7148_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00210-020-01832-2","volume":"393","author":"F Demir","year":"2020","unstructured":"Demir F, Demir M, Aygun H. Evaluation of the protective effect of Edaravone on doxorubicin nephrotoxicity by [99mTc] DMSA renal scintigraphy and biochemical methods. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(8):1383\u201390.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"7148_CR23","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.3390\/cimb45070340","volume":"45","author":"T Kawamoto","year":"2023","unstructured":"Kawamoto T, Sasai K. Edaravone exerts protective effects on mice intestinal injury without interfering with the anti-tumor effects of radiation. Curr Issues Mol Biol. 2023;45(7):5362\u201372.","journal-title":"Curr Issues Mol Biol"},{"key":"7148_CR24","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2022-0115","volume":"30","author":"T Kawamoto","year":"2022","unstructured":"Kawamoto T, Sasai K, Bayramoglu Z, Mokhtare B, Mendil AS, Coban TA, et al. Effect of taxifolin on methotrexate-induced oxidative and inflammatory oral mucositis in rats: biochemical and histopathological evaluation. J Appl Oral Sci. 2022;30:e20220115.","journal-title":"J Appl Oral Sci"},{"issue":"5","key":"7148_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","volume":"27","author":"T Kawamoto","year":"2021","unstructured":"Kawamoto T, Sasai K, Huang N, P\u00e9rez P, Kato T, Mikami Y, et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27(5):892\u2013903.","journal-title":"Nat Med"},{"issue":"3","key":"7148_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030379","volume":"10","author":"T Kawamoto","year":"2021","unstructured":"Kawamoto T, Sasai K, Kaseb AO, Mohamed YI, Malek AE, Raad II, et al. The impact of angiotensin-converting enzyme 2 (ACE2) expression on the incidence and severity of COVID-19 infection. Pathogens. 2021;10(3):379.","journal-title":"Pathogens"},{"key":"7148_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113480","volume":"19","author":"J Marinello","year":"2018","unstructured":"Marinello J, Delcuratolo M, Capranico G. Anthracyclines as topoisomerase II poisons: from early studies to new perspectives. Int J Mol Sci. 2018;19:3480. https:\/\/doi.org\/10.3390\/ijms19113480.","journal-title":"Int J Mol Sci"},{"key":"7148_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the Moon. Exp Mol Med. 2020;52:192\u2013203. https:\/\/doi.org\/10.1038\/s12276-020-0384-2.","journal-title":"Exp Mol Med"},{"key":"7148_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071717","volume":"10","author":"F Kullenberg","year":"2021","unstructured":"Kullenberg F, Degerstedt O, Calitz C, Pavlovi\u0107 N, Balgoma D, Gr\u00e5sj\u00f6 J, et al. In vitro cell toxicity and intracellular uptake of doxorubicin exposed as a solution or liposomes: implications for treatment of hepatocellular carcinoma. Cells. 2021;10:1717. https:\/\/doi.org\/10.3390\/cells10071717.","journal-title":"Cells"},{"key":"7148_CR30","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1096\/fj.01-0376com","volume":"15","author":"S Goto","year":"2001","unstructured":"Goto S, Ihara Y, Urata Y, Izumi S, Abe K, Koji T, et al. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase \u03c0. FASEB J. 2001;15:2702\u201314.","journal-title":"FASEB J"},{"issue":"30","key":"7148_CR31","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.2217\/fon-2017-0418","volume":"13","author":"RW McCullough","year":"2017","unstructured":"McCullough RW. US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits. Future Oncol. 2017;13(30):2823\u201352.","journal-title":"Future Oncol"},{"key":"7148_CR32","doi-asserted-by":"crossref","unstructured":"McCullough RW, Pinto CM, Horta LS, Soares AP, Carvalho BA, Ferreira E, Lages EB, Goulart GA. Nanoencapsulated doxorubicin prevents mucositis development in mice. Pharm. 2021;13(7):1021.","DOI":"10.3390\/pharmaceutics13071021"},{"issue":"1","key":"7148_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1269\/jrr.47.91","volume":"47","author":"H \u00dc\u00e7\u00fcnc\u00fc","year":"2006","unstructured":"\u00dc\u00e7\u00fcnc\u00fc H, Ertekin MV, Y\u00f6r\u00fck \u00d6, Sezen O, \u00d6zkan A, Erdo\u011fan F, et al. Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. J Radiat Res. 2006;47(1):91\u2013102.","journal-title":"J Radiat Res"},{"issue":"12","key":"7148_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082834","volume":"8","author":"F Yoshino","year":"2013","unstructured":"Yoshino F, Yoshida A, Nakajima A, Wada-Takahashi S, Takahashi SS, Lee MCI. Alteration of the redox state with reactive oxygen species for 5-fluorouracil-induced oral mucositis in hamsters. PLoS ONE. 2013;8(12):e82834.","journal-title":"PLoS ONE"},{"issue":"9","key":"7148_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094863","volume":"23","author":"H Nguyen","year":"2022","unstructured":"Nguyen H, Sangha S, Pan M, Shin DH, Park H, Mohammed AI, et al. Oxidative stress and chemoradiation-induced oral mucositis: a scoping review of in vitro, in vivo and clinical studies. Int J Mol Sci. 2022;23(9):4863.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"7148_CR36","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","volume":"76","author":"L Wang","year":"2016","unstructured":"Wang L, Chen Q, Qi H, Wang C, Wang C, Zhang J, et al. Doxorubicin-induced systemic inflammation is driven by the upregulation of toll-like receptor 4 (TLR4) and endotoxin leakage. Cancer Res. 2016;76(22):6631\u201342.","journal-title":"Cancer Res"},{"issue":"7","key":"7148_CR37","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4161\/cbt.7.7.6207","volume":"7","author":"-M Logan","year":"2008","unstructured":"Logan -M, Stringer RM, Bowen AM, Gibson JJ, Sonis RT, S., Keefe MK, D. Serum levels of NF-\u03baB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther. 2008;7(7):1139\u201345.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"7148_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-5-16","volume":"5","author":"A Meirovitz","year":"2010","unstructured":"Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, Peretz T, et al. Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer-a prospective pilot study. Radiat Oncol. 2010;5(1):16.","journal-title":"Radiat Oncol"},{"issue":"1","key":"7148_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01077-5","volume":"21","author":"S Shi","year":"2023","unstructured":"Shi S, Chen Y, Luo Z, Nie G, Dai Y. Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. Cell Commun Signal. 2023;21(1):61.","journal-title":"Cell Commun Signal"},{"key":"7148_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.061","volume":"637","author":"P Feng","year":"2022","unstructured":"Feng P, Yang Y, Liu N, Wang S. Baicalin regulates TLR4\/I\u03baB\u03b1\/NF\u03baB signaling pathway to alleviate inflammation in doxorubicin related cardiotoxicity. Biochem Biophys Res Commun. 2022;637:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"7148_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1600-0722.2005.00216.x","volume":"113","author":"V Lima","year":"2005","unstructured":"Lima V, Brito G, Cunha FDQ, Rebou\u00e7as C, Falc\u00e3o B, Augusto R, et al. Effects of the tumour necrosis factor-\u03b1 inhibitors Pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters. Eur J Oral Sci. 2005;113:210\u20137.","journal-title":"Eur J Oral Sci"},{"issue":"7","key":"7148_CR42","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.ajpath.2014.03.012","volume":"184","author":"RD Arifa","year":"2014","unstructured":"Arifa RD, Madeira MF, de Paula TP, Lima RL, Tavares LD, Menezes-Garcia Z, Souza DG. Inflammasome activation is reactive oxygen species dependent and mediates irinotecan-induced mucositis through IL-1\u03b2 and IL-18 in mice. Am J Pathol. 2014;184(7):2023\u201334.","journal-title":"Am J Pathol"},{"issue":"10","key":"7148_CR43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/jop.12775","volume":"47","author":"AAD Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo AAD, Araujo LDS, CACXD, RFDC, GADC, DVDS, et al. Protective effect of angiotensin II receptor blocker against oxidative stress and inflammation in an oral mucositis experimental model. J Oral Pathol Med. 2018;47(10):972\u201384.","journal-title":"J Oral Pathol Med"},{"key":"7148_CR44","doi-asserted-by":"publisher","unstructured":"Xie J, He C, An Y, Yang Y, Wang M, Shan Z, Du Y, Zhao Y, Fu W, Zhang H, Huang Y, Ma X, Zhao B. Dual anti-inflammatory and analgesic effects of Xipayi Mouth Rinse on radiation-induced oral mucositis: ethnopharmacological and preclinical evidence. J Ethnopharmacol. 2026;354:120501. https:\/\/doi.org\/10.1016\/j.jep.2025.120501. PMID: 40886869.","DOI":"10.1016\/j.jep.2025.120501"},{"key":"7148_CR45","doi-asserted-by":"crossref","unstructured":"Salcan I, Dilber M, Suleyman Z, Yucel N, Salcan, S, Kesan S, Suleyman H. Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in rats. J Appl Oral Sci. 2025;33:e20250007.","DOI":"10.1590\/1678-7757-2025-0007"},{"issue":"10","key":"7148_CR46","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013;25(10):1939\u201348.","journal-title":"Cell Signal"},{"issue":"4","key":"7148_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR. Regulated cell death pathways in doxorubicin-induced cardiotoxicity. Cell Death Dis. 2021;12(4):339.","journal-title":"Cell Death Dis"},{"key":"7148_CR48","doi-asserted-by":"crossref","unstructured":"Christidi E, Brunham LR, Song S, Chu L, Liang H, Chen J, Liang J, Huang Z, Chen X. Protective effects of dioscin against doxorubicin-induced hepatotoxicity via regulation of Sirt1\/FOXO1\/NF-\u03bab signal. Front Pharmacol. 2019;10:1030.","DOI":"10.3389\/fphar.2019.01030"},{"key":"7148_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1353029","volume":"15","author":"SR Botros","year":"2024","unstructured":"Botros SR, Matouk AI, Amin A, Heeba GH. Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1\/Nrf2\/NF-\u03baB\/TNF-\u03b1 signaling pathways. Front Pharmacol. 2024;15:1353029.","journal-title":"Front Pharmacol"},{"key":"7148_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.10.008","volume":"114","author":"YP Yuan","year":"2018","unstructured":"Yuan YP, Ma ZG, Zhang X, Xu SC, Zeng XF, Yang Z, et al. CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. J Mol Cell Cardiol. 2018;114:38\u201347.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"7148_CR51","first-page":"1407","volume":"19","author":"Y Pan","year":"2020","unstructured":"Pan Y, Li W, Feng Y, Xu J, Cao H. Edaravone attenuates experimental asthma in mice through induction of HO-1 and the Keap1\/Nrf2 pathway. Exp Ther Med. 2020;19(2):1407\u201316.","journal-title":"Exp Ther Med"},{"issue":"3","key":"7148_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1248\/bpb.b19-00944","volume":"43","author":"B Wang","year":"2020","unstructured":"Wang B, Lin W. Edaravone protects against pancreatic and intestinal injury after acute pancreatitis via nuclear factor-\u03baB signaling in mice. Biol Pharm Bull. 2020;43(3):509\u201315. https:\/\/doi.org\/10.1248\/bpb.b19-00944.","journal-title":"Biol Pharm Bull"},{"key":"7148_CR53","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S522011","author":"H Lei","year":"2025","unstructured":"Lei H, Wang M, Huang M, Fu X. Edaravone in digestive diseases\u2013a narrative review. Drug Des Devel Ther. 2025. https:\/\/doi.org\/10.2147\/DDDT.S522011.","journal-title":"Drug Des Devel Ther"},{"key":"7148_CR54","doi-asserted-by":"crossref","unstructured":"Lei H, Wang M, Huang M, Fu X, Dang R, Wang M, Li X, Wang H, Liu L, Wu Q, Xie P. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway. J Neuroinflammation. 2022;19(1),41.","DOI":"10.1186\/s12974-022-02400-6"},{"issue":"1","key":"7148_CR55","first-page":"218","volume":"26","author":"XP Cui","year":"2022","unstructured":"Cui XP, Ye JX, Lin H, Zhou H, Ye S, Mu JS. Effects of edaravone combined with oxiracetam on neuronal apoptosis in rats with cerebral infarction through targeting SIRT1\/NF-\u03baB inflammatory pathway. Eur Rev Med Pharmacol Sci. 2022;26(1):218\u201324.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7148_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114475","volume":"153","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Dai H, Lv M, Wang Y, Zheng Y, Luo J, et al. Edaravone alleviates sepsis-induced diaphragmatic dysfunction via Sirt1\/Nrf2 pathway. Int Immunopharmacol. 2025;153:114475.","journal-title":"Int Immunopharmacol"},{"key":"7148_CR57","doi-asserted-by":"crossref","unstructured":"Zhang Y, Dai H, Lv M, Wang Y, Zheng Y, Luo J, Li S, Jia CJ, Chen MN, Huang DD, Wu SF, Zeng CM, Liu ZQ, Zhang X. Edaravone promotes motoneuron survival and functional recovery after brachial plexus root avulsion and reimplantation in rats: Involvement of SIRT1\/TFEB pathway. Int Immunopharmacol. 2025;145:113686.","DOI":"10.1016\/j.intimp.2024.113686"},{"issue":"8","key":"7148_CR58","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1007\/s00210-024-02956-5","volume":"397","author":"EA -El-Shoura","year":"2024","unstructured":"-El-Shoura EA, Hassanein EH, Taha HH, Shalkami AGS, Hassanein MMH, Ali FE, et al. Edaravone and obeticholic acid protect against cisplatin-induced heart toxicity by suppressing oxidative stress and inflammation and modulating Nrf2, TLR4\/p38MAPK, and JAK1\/STAT3\/NF-\u03baB signals. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(8):5649\u201362.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"7148_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105967","volume":"77","author":"C Bailly","year":"2019","unstructured":"Bailly C. Potential use of Edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers. Int Immunopharmacol. 2019;77:105967.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"7148_CR60","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"7148_CR61","doi-asserted-by":"crossref","unstructured":"El-Arabey AA. Gender difference in Cisplatin-induced nephrotoxicity in a rat model. Nephro-Urol Mon. 2015;7(2),e23595.","DOI":"10.5812\/numonthly.23595"},{"key":"7148_CR62","doi-asserted-by":"crossref","unstructured":"Llamas-Ramos I, Alvarado-Omenat JJ, Rodrigo-Reguil\u00f3n M, Llamas-Ramos R. Quality of life and side effects managementin cancer treatment\u2014a cross sectional study. Int J Environ Res Public Health. 2023;20(3):1708.","DOI":"10.3390\/ijerph20031708"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-07148-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:10:41Z","timestamp":1764173441000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-07148-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7148"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-07148-y","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the local ethics committee Tokat Gaziosmanpa\u015fa University (2020 HADYEK-15; Approval number: 51879863-105).The animals used in this study were obtained from the Experimental Animal Research Center of Tokat Gaziosmanpa\u015fa University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1841"}}